Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies

1 Jan 2020

Abstract excerpt

testing of galectin inhibitors against SARS-CoV-2. In addition, it warrants a swift examination of TD-139 for treating COVID-19.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Galectins and Cancer Biology
Share to Toxin Mechanisms and Immunotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35518264
DOI: 10.1039/d0ra04795c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studiesPMID 35518264Read ↗

Chasing COVID-19 through SARS-CoV-2 spike glycoproteinSemantic proximity Read ↗

Galectin approach to lower covid transmission - Drug Development for clinical useSemantic proximity Read ↗

Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trialSemantic proximity Read ↗

The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapySemantic proximity Read ↗

Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19Semantic proximity Read ↗

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replicationSemantic proximity Read ↗

Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an in silico ApproachSemantic proximity Read ↗

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic DrugsSemantic proximity Read ↗

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitroSemantic proximity Read ↗

In-silico analysis of potential interaction of drugs and the SARS-CoV-2 spike proteinSemantic proximity Read ↗

A Multi-Targeting Approach to Fight SARS-CoV-2 AttachmentSemantic proximity Read ↗

Protein <i>N</i> -glycosylation is essential for SARS-CoV-2 infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.